NEW YORK (GenomeWeb News) – Multiplicom has raised €5.5 million ($7.3 million) to support further development of its molecular diagnostic tests and expansion of its business.

Flemish investment firm PMV, RMM (Rudi Mariën) and Qbic ARKIV Fund were new investors in the round. Existing investors including Belgian venture capital firm Gimv, Gimv-managed Biotechfonds Vlaanderen, and life science research institute VIB continue to support Multiplicom, it said, adding VIB will make an investment in kind.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.